CARGO Therapeutics (CRGX) Competitors

CARGO Therapeutics (NASDAQ:CRGX) and Nuvation Bio (NYSE:NUVB) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, community ranking, earnings, risk, media sentiment, profitability, dividends, analyst recommendations and valuation.

Does the media favor CRGX or NUVB?

In the previous week, Nuvation Bio had 17 more articles in the media than CARGO Therapeutics. MarketBeat recorded 18 mentions for Nuvation Bio and 1 mentions for CARGO Therapeutics. CARGO Therapeutics' average media sentiment score of 1.89 beat Nuvation Bio's score of 0.50 indicating that CARGO Therapeutics is being referred to more favorably in the media.

Company	Overall Sentiment
CARGO Therapeutics	Very Positive
Nuvation Bio	Neutral

Do insiders and institutionals hold more shares of CRGX or NUVB?

93.2% of CARGO Therapeutics shares are owned by institutional investors. Comparatively, 61.7% of Nuvation Bio shares are owned by institutional investors. 2.9% of CARGO Therapeutics shares are owned by company insiders. Comparatively, 29.9% of Nuvation Bio shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Is CRGX or NUVB more profitable?

Nuvation Bio's return on equity of -21.89% beat CARGO Therapeutics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CARGO Therapeutics	N/A	-38.16%	-33.94%
Nuvation Bio	N/A	-21.89%	-17.86%

Do analysts rate CRGX or NUVB?

CARGO Therapeutics presently has a consensus price target of $15.00, indicating a potential upside of 235.95%. Nuvation Bio has a consensus price target of $7.83, indicating a potential upside of 351.49%. Given Nuvation Bio's stronger consensus rating and higher probable upside, analysts plainly believe Nuvation Bio is more favorable than CARGO Therapeutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CARGO Therapeutics	1 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.86
Nuvation Bio	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	1 Strong Buy rating(s)	3.17

Which has more volatility & risk, CRGX or NUVB?

CARGO Therapeutics has a beta of 0.31, suggesting that its stock price is 69% less volatile than the S&P 500. Comparatively, Nuvation Bio has a beta of 1.37, suggesting that its stock price is 37% more volatile than the S&P 500.

Does the MarketBeat Community prefer CRGX or NUVB?

Nuvation Bio received 45 more outperform votes than CARGO Therapeutics when rated by MarketBeat users. Likewise, 80.82% of users gave Nuvation Bio an outperform vote while only 66.67% of users gave CARGO Therapeutics an outperform vote.

Company	Underperform	Outperform
CARGO Therapeutics	Outperform Votes 14 66.67%	Underperform Votes 7 33.33%
Nuvation Bio	Outperform Votes 59 80.82%	Underperform Votes 14 19.18%

Which has preferable earnings and valuation, CRGX or NUVB?

Nuvation Bio has higher revenue and earnings than CARGO Therapeutics. CARGO Therapeutics is trading at a lower price-to-earnings ratio than Nuvation Bio, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CARGO Therapeutics	N/A	N/A	-$98.15M	-$4.62	-0.97
Nuvation Bio	$10.96M	53.88	-$75.80M	-$2.35	-0.74

Summary

Nuvation Bio beats CARGO Therapeutics on 15 of the 17 factors compared between the two stocks.